Abstract
Within the intricate capillary and bronchial network of the lungs are found important cellular sources for eicosanoids, cytokines, surfactant and the potent endothelium derived-vasoconstrictor, endothelin-1 [1–3]. In large mammals, the lungs contain only 12% of total blood volume at any given time yet the cross-sectional area of the pulmonary circulation represents 40% of that of the entire vasculature [4]. This would suggest that the pulmonary vascular endothelium has the potential capacity of producing and concentrating in the lungs a significant portion of the total vascular-derived endothelin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blackwell GJ, Flower RJ, Nijkamp FP, Vane JR (1978) Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids. Br J Pharmacol 62: 79–89
Bry K, Lappalainen U, Hallman M (1996) Cytokines and production of surfactant components. Semin Perinatol 20: 194–205
Barnes PJ (1994) Endothelins and pulmonary diseases. J Appl Physiol 77: 1051–1059
Milner WR (1982) Hemodynamics. Williams & Wilkins, Baltimore.
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide is produced by vascular endothelial cells. Nature 332: 411–415
Ferri C, Bellini C, de Angelis C, de Siati L, Perrone A, Properzi G, Santucci A (1995) Circulating endothelin-1 concentrations in patients with chronic hypoxia. J Clin Pathol 48: 519–524
Feng CS, Huang NQ, Zeng Q (1993) Determination of plasma endothelin-1 in aged patients with chronic obstructive pulmonary disease in its clinical significance. Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih 16: 287–289
Schersten H, Aarnio P, Burnett JC jr, McGregor CG, Miller VM (1994) Endothelin-1 in bronchoalveolar lavage during rejection of allotransplanted lungs. Transplantation 57: 159–161
Sessa WC, Kaw S, Hecker M, Vane JR (1991) The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 174: 613–618
Black PN, Ghatei MA, Takahashi K, Bremerton-Watt D, Krausz T, Dollery CT, Bloom SR (1989) Formation of endothelin by cultured airway epithelial cells. FEBS Lett 255: 129–132
Laporte J, D’Orléans-Juste P, Sirois P (1996) Guinea pig clara cells secrete endothelin-1 through a phosphoramidon-sensitive pathway. Am J Respir Cell Mol Biol 14: 356–362
Takeda Y, Itoh Y, Yoneda T, Miyamori I, Takeda R (1993) Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells. Eur J Pharmacol 223: 299–301
Battistini B, D’Orléans-Juste P, Sirois P (1993) Endothelin involvement in physiopathologies: Circulating plasma levels and presence in biological fluids. Lab Invest 68: 600–628
Giaid A, Saleh D (1995) Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333: 214–221
Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328: 1732–1739
Sutsch G, Bertel O, Kiowski W (1996) Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans. Cardiovasc Drugs Ther 10: 717–725
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863–2867
McMahon EG, Palomo MA, Moore WM, McDonald JF, Stern MK (1991) Phosphoramidon blocks the pressor activity of porcine big endo helin-1-(1–39) in vivo and conversion of big endothelin-1-(1–39) to endothelin-1-(1–21) in vitro. Proc Natl Acad Sci USA 88: 703–707
Takahashi M, Matsumura Y, Iijma Y, Tanzawa K (1993) Purification and characterization of endothelin converting enzyme from rat lung. J Biol Chem 268: 21394–21398
Xu D, Emoto N, Giaid A, Slaughter CKS, deWit D, Yanagisawa M (1994) ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big-endothelin-1. Cell 78: 473–485
Emoto N, Yanagisawa M (1995) Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270: 15262–15268
Shimada K, Takahashi M, Ikeda M, Tanzawa K (1995) Identification and characterization of two isoforms of an endothelin-converting enzyme-1. FEBS Lett 371: 140–144
Barnes K, Murphy LJ, Takahashi M, Tanzawa K, Turner AJ (1995) Localization and biochemical characterization of endothelin-converting enzyme. J Cardiovasc Pharmacol 29: S37–S39
Shimada K, Takahashi M, Turner AJ, Tanzawa K (1996) Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism a distinct substrate binding mechanism compared with neutral endopeptidase 24–11. Biochem J 315: 863–867
Turner AJ, Tanzawa K (1997) Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 11: 355–364
Sawamura T, Shinmi O, Kishi N, Sugita Y, Yanagisawa M, Goto K, Masaki T, Kimura S (1993) Characterization of phosphoramidon-sensitive metalloproteinase with endothelin-converting enzyme activity in porcine lung membrane. Biochem Biophys Acta 1161: 295–302
Wypij DM, Nichols JS, Novak PJ, Stacy DL, Berman J, Wiseman JS (1992) Role of mast cell chymase in the extracellular processing of big-endothelin-1 to endothelin-1 in the perfused lung. Biochem Pharmacol 43: 845–853
Saleh D, Furukawa K, Tsao MS, Maghazachi A, Corrin B, Yanagisawa M, Barnes PJ, Giaid A (1997) Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines. Am J Respir Cell Mol Biol 16: 187–193
de Nucci G, Thomas R, D’Orléans-Juste P, Antunes E, Walder C, Warner TD, Vane JR (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797–9800
Weitzberg E, Lundberg JM, Rudehill A (1995) Inhibitory effects of diclofenac on the endotoxin shock response in relation to endothelin turnover in the pig. Acta Anaesthesiol Scand 39: 50–59
Oka M, Hasunuma K, Webb, Stelzner TJ, Rodman DM, McMurty IF (1993) EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am J Physiol 264: L587–L597
Takahashi M, Fukuda K, Shimada K, Barnes K, Turner AJ, Ikeda M, Koike H, Yamamoto Y, Tanzawa K (1995) Localization of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells. Biochem J 311: 657–665
Hemsen A, Pernow J, Lundberg JM (1991) Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig. Acta Physiol Scand 141: 325–334
Kashiwabara T, Inagaki Y, Ohta H, Iwamatsu A, Nozimu M, Morita A, Nishikori K (1989) Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo. FEBS Lett 247: 73–76
Macarthur H, Warner TD, Wood EG, Corder R, Vane JR (1994) Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 200: 395–400
Vemulapalli S, Rivelli M, Chiu PJ, delPrado M, Hey JA (1992) Phosphoramidon abolishes the increase in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea-pig lungs. J Pharmacol Exp Ther 262: 1062–1069
Advenier C, Lagente V, Zhang Y, Naline E (1992) Contractile activity of big endothelin-1 on the human isolated bronchus. Br J Pharmacol 106: 883–887
Pons F, Touvay C, Lagente V, Mencia-Huerta JM, Braquet P (1992) Involvement of phosphoramidon-sensitive endopeptidase in the processing of big-endothelin-1 in the guinea-pig. Eur J Pharmacol 217: 65–70
Laporte J, D’Orléans-Juste P, Singh G, Sirois P (1995) Dexamethasone and phosphoramidon inhibit endothelin release by cultured nonciliated bronchiolar epithelial (Clara) cells. J Cardiovasc Pharmacol 26: S53–S55
Calderon E, Gomez-Sanchez CE, Cozza EN, Zhou M, Coffey RG, Lockey RF, Prockop LD, Szentivanyi A (1994) Modulation of endothelin-1 production by a pulmonary epithelial cell line. I. Regulation by glucocorticoids. Biochem Pharmacol 48: 2065–2071
Mattoli S, Soloperto M, Marini M, Fasoli A (1991) Levels of endothelin in the broncho-alveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J Allergy Clin Immunol 88: 376–384
Redington AE, Springall DR, Ghatei MA, Lau LC, Bloom SR, Holgate ST, Polak JM, Howart PH (1995) Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am J Resp Crit Care Med 151: 1034–1039.
Borson DB, Gruenert DC (1991) Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol 260: L83–L89
Gratton JP, Rae GA, Claing A, Télémaque S, D’Orléans-Juste, P (1995) Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1–38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs. Br J Pharmacol 114: 720–726
Pons F, Touvay C, Lagente V, Mencia-Huerta JM, Braquet P (1991) Comparison of the effect of intra-arterial and aerosol administration of endothelin-1 (ET-1) in the guinea-pig isolated lung. Br J Pharmacol 102: 791–796
Gratton JP, Maurice MC, D’Orléans-Juste P (1995) Characterization of endothelin receptors and endothelin-converting enzyme activity in the rabbit lung. J Cardiovasc Pharmacol 26: S88–S90
Gratton JP, Maurice MC, Rae GA, D’Orléans-Juste P (1995) Pharmacological properties of endothelins and big-endothelins in ketamine/xylazine or urethane anesthetized rats. Am J Hypertens 8: 1121–1127
D’Orléans-Juste P, Gratton JP, Bkaily G, Claing A (1996) L’endothéline: de la pharmacologie moléculaire à ses implications en physiopathologie. Méd Sci 12: 563–574
Whittle BJ, Payne AN, Esplugues JV (1989) Cardiopulmonary and gastric ulcerogenic actions of endothelin-1 in the guinea pig and rat. J Cardiovasc Pharmacol 13: S103–S107
Ignarro LJ (1996) Physiology and pathophysiology of nitric oxide. Kidney Int 55: S2–S5
Boulanger C, Luscher TF (1990) Release of endothelin form the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587–590
Gratton JP, Cournoyer G, Löffler BM, Sirois P, D’Orléans-Juste P (1997) ETB receptor and nitric oxide synthase blockades induce BQ-123-sensitive pressor effects in the anaesthetized rabbit. Hypertension 30: 1204–1209
Dupuis J, Stewart DJ, Cernacek P, Gosselin G (1996) Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 94: 1578–1584
Russell FD, Davenport AP (1995) Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB 209670 and 97–139. J Cardiovasc Pharmacol 26: S346–S347
Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M (1994) Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199: 1461–1465
Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T et al (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91: 4892–4896
Dupuis J, Goresky CA, Fournier A (1996) Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol 81: 1510–1515
Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a non-peptide-selective subtype of the endothelin receptor. Nature 348: 732–735
Neuser D, Steinke W, Dellweg H, Kazda S, Stasch JP (1991) 125I-endothelin-l and 125I-big endothelin-1 in rat tissues: autoradiographic localization and receptor binding. Histochemistry 95: 621–628
Warner TD, Mitchell JA, de Nucci G, Vane JR (1989) Endothelin-1 and endothelin-3 release EDRF from isolated arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 13: S85–S88
De Lombaert S, Ghai RD, Jeng AY, Trapani AJ, Webb RL (1994) Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem Biophys Res Communun 204; 407–412
Gardiner SM, Kemp PA, Bennett T (1992) Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1–38] in concious rats. Br J Pharmacol 106: 180–186
Ashizawa N, Okumura H, Kobayashi F, Aotsuka T, Takahashi M, Asakura R, Arai K, Matsuura A (1994) Inhibitory activities of metal chelators on endothelin-converting enzyme. I. In vitro studies. Biol Pharm Bull 17: 207–211
Ashizawa N, Okumura H, Kobayashi F, Aotsuka T, Asakura R, Arai K, Ashikawa N, Matsuura A (1994) Inhibitory activities of metal chelators on endothelin-converting enzyme. II. In vivo studies. Biol Pharm Bull 17: 212–216
Claing A, Neugebauer W, Yano M, Rae G, D’Orléans-Juste P (1995) [Phe22]-big endothelin-1 [19–37]: a new and potent inhibitor of the endothelin-converting enzyme. J Cardiovasc Pharmacol 26: S72–S74
Morita A, Nomizu M, Okitsu M, Horie K, Yokogoshi H, Roller PP (1994) D-Val22 containing human big endothelin-1 analog, [D-Val22]Big ET-1 [16–38], inhibits the endothelin converting enzyme. FEBS Lett 353: 84–88
Poulat P, de Champlain J, D’Orléans-Juste P, Couture R (1996) Receptor and mechanism that mediate endothelin-and big endothelin-1-induced phosphoinositide hydrolysis in the rat spinal cord. Eur J Pharmacol 315: 327–334
Kurihara K, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R et al (1994) Elevated blood pressure in craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703–710
Yanagisawa M (1995) Molecular genetic dissection of the endothelin system. C.O.E. International Symposium (Osaka, Japan) (Abstract 0–21)
Giaid A, Michel RP, Stewart DJ, Sheppard M, Corrin B, Hamid Q (1993) Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 341: 1550–1554
Battistini B, Forget MA, Laight D (1996) Potential roles for endothelins in systemic inflammatory response syndrome with particular relationship to cytokines. Shock 5: 167–183
Stankova J, D’Orléans-Juste P, Rola-Pleszczynski M (1996) ET-1 induces IL-6 gene expression in human umbilical vein endothelial cells — synergistic effect of IL-1. Am J Physiol 271: C1073–C1078.
Ivy DD, Le Cras, Horan MP, Abman SH (1998) Increased lung prepro ET-1 and decreased ETB-receptor gene expression in fetal pulmonary hypertension. Am J Physiol 274: L535–L541
Filep JG, Bodolay E, Sipka S, Gyimesi E, Csipo I, Szegedi G (1995) Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease. Circulation 92: 2969–2974
Matsumura Y, Umekawa T, Kawamura H, Takaoka M, Robinson PS, Cook ND, Morimoto S (1992) A simple method for measurement of phosphoramidon-sensitive endothelin converting enzyme activity. Life Sci 51: 1603–1611
Gui G, Xu D, Emoto N, Yanagisawa M (1993) Intracellular localization of membrane-bound endothelin-converting enzyme from rat lung. J Cardiovasc Pharmacol 22: S53–S56
Shima M, Yamanouchi M, Omori K, Sugiura M, Kawashima K, Sato T (1995) Endothelin-1 production and endothelin converting enzyme expression by guinea pig airway epithelial cells. Biochem Mol Biol Int 37: 1001–1010
Shima H, Kawashima Y, Ohmori K, Sugiura M, Kawashima K (1994) Endothelin-converting enzymes in guinea-pig lung membrane fractions: purifications and characterizations. Biochem Mol Biol Int 34: 1227–1234
Kundu GC, Wilson IB (1992) Identification of endothelin converting enzyme in bovine lung membranes using a new fluorogenic substrate. Life Sci 50: 965–970
Shimada K, Takahashi M, Tanzawa K (1994) Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 269: 18275–18278
Kent A, Keenan AK (1995) Evidence for signalling by big endothelin-1 via conversion to endothelin-1 in pulmonary artery smooth muscle cells. Life Sci 57: 1191–1196
Lebel N, D’Orléans-Juste P, Fournier A, Sirois P (1996) Role of neutral endopeptidase 24.11 in the conversion of big-endothelins in guinea pig lung parenchyma. Br J Pharmacol 117: 184–188
Battistini B, Brown M, Vane JR (1995) Selective proteolitic activation and degradation of ETs and Big-ETs in parenchymal strips of the guinea-pig lung. Biochem Biophys Res Commun 207: 675–681
Lehoux S, Plante GE, Sirois MG, Sirois P, D’Orléans-Juste P (1992) Phosphoramidon blocks big-endothelin-1 but not endothelin-1 enhancement of vascular permeability in the rat. Br J Pharmacol 107: 996–1000
Lebel N, D’Orléans-Juste P, Fournier A, Sirois P (1995) Characterization of the endothelin-converting enzyme in guinea-pig upper bronchus. J Cardiovasc Pharmacol 26: S81–S83
D’Orléans-Juste P, Lidbury PS, Télémaque S, Warner TD, Vane JR (1991) Human big-endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1. J Cardiovasc Pharmacol 17: S251–S255
Mattera GG, Catalioto RM, Criscuoli M, Subissi A (1994) Endothelins induce prostacyclin release in both vascular and non-vascular tissues. Nauyn Schmied Arch Pharmacol 350: 410–415
Langleben D, Long WA, Barst RJ, Tapson VF, Groves M, Badesch DB, Bourge RC, Murali S, Ettinger N, Shalit E, Stewart DJ & The North American Primary Pulmonary Hypertension Study Group (1995) Prostacyclin infusion improves the balance between pulmonary clearance and production of endothelin-1 in patients with primary pulmonary hypertension. Circulation 92: 1–241
Mattoli S, Mezzetti M, Riva G, Allegra L, Fasoli A (1990) Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol 3(2) 145–151
Gosselin R, Gutkowska J, Baribeau J, Penneault T (1997) Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn Piglet. Am J Physiol 273: L72–L79
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Birkhäuser Verlag
About this chapter
Cite this chapter
D’Orléans-Juste, P., Gratton, JP., Bkaily, G., Giaid, A. (1999). Activity and Distribution of the Endothelin-Converting Enzyme in the Lung. In: Goldie, R.G., Hay, D.W.P. (eds) Pulmonary Actions of the Endothelins. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-8821-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8821-9_4
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-5859-4
Online ISBN: 978-3-0348-8821-9
eBook Packages: Springer Book Archive